Tempus AI and Northwestern University's Abrams Research Center are collaborating to apply AI-driven data analytics to genomic data focused on Alzheimer's disease. Using Tempus’ Lens platform, the partnership seeks to uncover genomic patterns relevant to disease progression, identify affected genes and cell types, and accelerate development of therapeutics and clinical applications. This integration of AI with neurogenomics represents a promising advancement in understanding and treating Alzheimer’s, a condition with severe public health impacts worldwide.